FLC
ARCK

Fifth Lane Capital’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Fifth Lane Capital’s Portfolio ARCK Stock Details ARCK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50,000
Closed -$498K – 424
2021
Q4 		$498K Buy
+50,000
New +$496K 0.29% 99

Other funds holding ARCK

SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Fifth Lane Capital's ARCK Position: Q1 2022 in Review

Fifth Lane Capital sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q1 2022, closing a stake of 50,000 shares — an estimated $498K sold.

Fifth Lane Capital first reported a position in ARCK in Q4 2021 and held it in 1 quarter. The position peaked at $498K in Q4 2021. 52 funds tracked by Wall St. Rank hold ARCK as of Q1 2022.

  • Fifth Lane Capital reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Fifth Lane Capital sold 50,000 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q1 2022, an estimated $498K.
  • Fifth Lane Capital first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q4 2021 and held it in 1 quarter.
  • Fifth Lane Capital's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $498K in Q4 2021.
  • 52 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q1 2022.

Based on Fifth Lane Capital's 13F filing for Q1 2022, filed 16 May 2022.